FocusPerformancePartnership
About Astorg

Our depth creates opportunity

We’re a private equity firm, headquartered in Luxembourg, with a resolutely European focus, and with deep specialism in three high-opportunity sectors, where our proven experience in investment and value creation unlocks growth for international B2B leaders.

Chatgpt Image Sep 19, 2026, 04 07 17 Pm V2
9855 Lau 3122©laurinepaumardphotographe

Astorg in numbers

27 Years
Years of investment track record
€24bn
Assets Under Management
6
Offices in Europe and North America
16
Active Partners
47%
of Astorg collectively own alongside our Co-Founders and senior leaders
>200
Employees

Depth creates opportunity

Depth starts with Focus.

Deep knowledge in our core areas of expertise - Healthcare, Technology and Business Services - allowing us to uncover the opportunity and potential that others might miss. Giving us the insight and conviction to act decisively. 

Depth generates Performance.

We combine disciplined investing with deep value-creation capabilities. Innovating to accelerate growth and drive impact. Always execution and results focused. Consistently delivering. 

Depth is also in Partnership.

Hands-on and entrepreneurial by design.  We listen. We align. We build trust. Because building lasting businesses with management teams takes more than capital. And because delivering value for investors means more than returns. We take everyone on a shared journey of value creation. 

Astorg Identity Asset
Benjamin Cordonnier

“Specialization is a choice: depth over breadth. So is our culture: our most senior people work alongside teams, uncovering opportunities others may miss. Independence lets us act on them with conviction. Together, they form the foundation of our performance."


Benjamin Cordonnier

Co-Managing Partner & CEO

FocusPerformancePartnershipFocusPerformancePartnershipFocusPerformancePartnershipFocusPerformancePartnershipFocusPerformancePartnership
PARTNERSHIP

Depth in Partnership at Astorg

We are an independent, partner-owned firm, led by people with a direct and long-term stake in Astorg’s success.

Our Executive Chairman and Co-Managing Partners work closely together to shape the firm’s direction. The Executive Chairman focuses on long-term strategy, investor relationships and the continuity of Astorg’s culture, while remaining actively involved in our Investment Committees. The Co-Managing Partners lead the firm day to day and oversee the execution of our strategic priorities.

Today, 16 active partners collectively own approximately 47% of Astorg alongside our Co-Founders and senior leaders. This broad ownership supports continuity across generations and keeps the people leading the firm closely aligned with its long-term success.

This model preserves the entrepreneurial spirit of a partnership while providing the governance and discipline of a scaled investment platform.

Executive Committee

Our Executive Committee brings together expertise across investment, portfolio performance, human capital, investor relations and corporate operations. A structured committee framework provides clear oversight and accountability, while enabling informed debate and effective decision-making.

Latest company news

Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
ViewMore
Corporate News
news
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
ViewMore
Corporate News
news
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
ViewMore
Corporate News
news
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
ViewMore
Corporate News
news
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate